they kill CLL cells but don’t harm healthy ones. But it’s too soon to know if that’s true in people or what the right dose is. Remember, supplements can’t treat cancer and don’t take the place of medical treatments. If you’re thinking about taking something, talk to your onco...
That said, keep in mind this is “chronic” lymphocytic leukemia, meaning it also is “slow.” So you can read it and try one new thing at a time. No rush. (But no junk food either:) The second source for this information is aLife Extension articlefrom many years ago. The facts ar...
The patient was treated with 600mg/m2 rituximab weekly followed by eight courses of biweekly therapy and then by long-term maintenance therapy, achieving almost complete remission of the symptoms and disease control. CONCLUSIONS: After resistance to standard chemotherapy with chlorambucil and fludarabine...
That doesn’t help the long-term outcome. The longer one can wait, the more likely they are to shift into a new era, where we might have even more effective and better-tolerated drugs. That’s some great wisdom. I like the mention of “watch and worry” because that comes up ...
The people from MD Anderson Cancer Center would argue that for a patient who is young, fit, with no mutation, non-del(17p), probably trisomy 12 or del(13q), you should at least discuss it because in the long-term follow-up data, there is a theoretical tail on the curve...
In addition, analysis of transplanted samples revealed that absence of AID resulted in a trend towards higher clonal stability, meaning that dominant IGHV clones in primary samples reappeared in the transplanted tumors, whereas presence of AID yielded expansion of previously minor clones in 3 out 12...
Since ‘b’ is the proliferation rate of T cells due to cancer antigen-presenting cells in the blood of cancer relapse patients, this term behaves similarly to the external re-infusion and similar behavior is observed graphically in Figure 9. Figure 9. Graphs of sensitivity with respect to b...